Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Leukemia 45Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Burkitt Lymphoma 12Leukemia, Biphenotypic, Acute 9Recurrence 8Lymphoma 8Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, T-Cell 4Leukemia, Myeloid, Acute 3Neoplasms 2Neoplasm, Residual 2Lymphoma, T-Cell 2Down Syndrome 2Mucositis 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphoid 1Leukemia, B-Cell 1Immunoproliferative Disorders 1Hematologic Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Blast Crisis 1

Interventions

Cytarabine 4Cyclophosphamide 4Amifostine 4Etoposide 3sargramostim 2Voriconazole 2Radiotherapy 2Methotrexate 2pegaspargase 1glucarpidase 1Vincristine 1Silymarin 1Pyridostigmine Bromide 1Prednisolone 1Phenobarbital 1Mitoxantrone 1Methylprednisolone 1Mercaptopurine 1Leucovorin 1Irinotecan 1Ifosfamide 1Idarubicin 1Hydrocortisone 1Filgrastim 1Fibroblast Growth Factor 7 1Epoetin Alfa 1Doxorubicin 1Dexrazoxane 1Dexamethasone 1Deoxycytidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × pegaspargase × Other hematologic neoplasm × Clear all
NCT00400946 2026-02-13

05-001: Treatment of Acute Lymphoblastic Leukemia in Children

Dana-Farber Cancer Institute

Phase 3 Completed
800 enrolled 22 charts
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡